Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
About this item
Full title
Author / Creator
Baughman, Robert P , Drent, Marjolein , Kavuru, Mani , Judson, Marc A , Costabel, Ulrich , du Bois, Roland , Albera, Carlo , Brutsche, Martin , Davis, Gerald , Donohue, James F , Muller-Quernheim, Joachim , Schlenker-Herceg, Rozsa , Flavin, Susan , Lo, Kim Hung , Oemar, Barry , Barnathan, Elliot S , on behalf of Sarcoidosis Investigators , on behalf of the Sarcoidosis Investigators and Sarcoidosis Investigators
Publisher
New York, NY: Am Thoracic Soc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Am Thoracic Soc
Subjects
More information
Scope and Contents
Contents
Evidence suggests that tumor necrosis factor (TNF)-alpha plays an important role in the pathophysiology of sarcoidosis.
To assess the efficacy of infliximab in sarcoidosis.
A phase 2, multicenter, randomized, double-blind, placebo-controlled study was conducted in 138 patients with chronic pulmonary sarcoidosis. Patients were randomized to re...
Alternative Titles
Full title
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Authors, Artists and Contributors
Author / Creator
Drent, Marjolein
Kavuru, Mani
Judson, Marc A
Costabel, Ulrich
du Bois, Roland
Albera, Carlo
Brutsche, Martin
Davis, Gerald
Donohue, James F
Muller-Quernheim, Joachim
Schlenker-Herceg, Rozsa
Flavin, Susan
Lo, Kim Hung
Oemar, Barry
Barnathan, Elliot S
on behalf of Sarcoidosis Investigators
on behalf of the Sarcoidosis Investigators
Sarcoidosis Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68872740
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68872740
Other Identifiers
ISSN
1073-449X
E-ISSN
1535-4970
DOI
10.1164/rccm.200603-402OC
